IO Biotech, Inc. - Common Stock, par value $0.001 per share (IOBTQ)
CUSIP: 449778109
Q3 2022 13F Holders as of 30 Sep 2022
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 73,755,848
- Total 13F shares
- 15,335,530
- Share change
- -118,027
- Total reported value
- $41,559,000
- Price per share
- $2.71
- Number of holders
- 20
- Value change
- -$326,875
- Number of buys
- 8
- Number of sells
- 6
Quarterly Holders Quick Answers
What is CUSIP 449778109?
CUSIP 449778109 identifies IOBTQ - IO Biotech, Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 449778109:
Top shareholders of IOBTQ - IO Biotech, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Novo Holdings A/S |
13F
|
Company |
4.4%
|
3,277,932
|
$15,308,000 | — | 30 Jun 2022 | |
| Vivo Capital, LLC |
13F
|
Company |
4.1%
|
3,015,545
|
$14,083,000 | — | 30 Jun 2022 | |
| PFM Health Sciences, LP |
13F
|
Company |
2.9%
|
2,159,155
|
$10,083,000 | — | 30 Jun 2022 | |
| Avoro Capital Advisors LLC |
13F
|
Company |
2.8%
|
2,055,883
|
$9,601,000 | — | 30 Jun 2022 | |
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
2.5%
|
1,857,755
|
$8,676,000 | — | 30 Jun 2022 | |
| Capital World Investors |
13F
|
Company |
1.7%
|
1,235,000
|
$5,767,000 | — | 30 Jun 2022 | |
| Samsara BioCapital, LLC |
13F
|
Company |
1.4%
|
1,008,437
|
$4,709,000 | — | 30 Jun 2022 | |
| Soleus Capital Management, L.P. |
13F
|
Company |
0.89%
|
655,404
|
$3,061,000 | — | 30 Jun 2022 | |
| HBM Healthcare Investments (Cayman) Ltd. |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
2,690,545
|
$2,784,714 | — | 09 Nov 2021 | |
| Claus A. Andersson |
3/4/5
|
Director |
—
class O/S missing
|
1,791,490
|
$1,854,192 | — | 09 Nov 2021 | |
| Vanessa Malier |
3/4/5
|
Director |
—
class O/S missing
|
430,477
|
$445,544 | — | 09 Nov 2021 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.1%
|
75,000
|
$350,000 | — | 30 Jun 2022 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.06%
|
46,231
|
$216,000 | — | 30 Jun 2022 | |
| MORGAN STANLEY |
13F
|
Company |
0.03%
|
24,109
|
$113,000 | — | 30 Jun 2022 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.02%
|
14,426
|
$67,000 | — | 30 Jun 2022 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.02%
|
12,730
|
$59,000 | — | 30 Jun 2022 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.01%
|
10,000
|
$47,000 | — | 30 Jun 2022 | |
| UBS Group AG |
13F
|
Company |
0%
|
2,234
|
$10,000 | — | 30 Jun 2022 | |
| CANNELL CAPITAL LLC |
13F
|
Company |
0%
|
2,192
|
$10,000 | — | 30 Jun 2022 | |
| CITIGROUP INC |
13F
|
Company |
0%
|
1,000
|
$5,000 | — | 30 Jun 2022 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
524
|
$2,000 | — | 30 Jun 2022 | |
| Keith A. Vendola |
3/4/5
|
Chief Financial Officer |
—
class O/S missing
|
69,469
|
— | — | 04 Nov 2021 |
Institutional Holders of IO Biotech, Inc. - Common Stock, par value $0.001 per share (IOBTQ) as of Q3 2022
As of 30 Sep 2022,
IO Biotech, Inc. - Common Stock, par value $0.001 per share (IOBTQ) was held by
20 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
15,335,530 shares.
The largest 10 holders included
Novo Holdings A/S, Vivo Capital, LLC, PFM Health Sciences, LP, Avoro Capital Advisors LLC, RA CAPITAL MANAGEMENT, L.P., Capital World Investors, Samsara BioCapital, LLC, Soleus Capital Management, L.P., Newtyn Management, LLC, and BRIDGEWAY CAPITAL MANAGEMENT, LLC.
This page lists
20
institutional shareholders reporting positions in this security
for the Q3 2022 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2022 vs Q2 2022 Across Filers
Q2 2022 holders
18
Q3 2022 holders
20
Holder diff
2
| Investor | Q2 2022 Shares | Q3 2022 Shares | Share Diff | Share Chg % | Q2 2022 Value $ | Q3 2022 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.